TAP-311

CAS No. 1149362-88-8

TAP-311( TAP311 )

Catalog No. M10527 CAS No. 1149362-88-8

TAP-311 is a novel potent and selective CETP inhibitor with plasma IC50 of 62 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    TAP-311
  • Note
    Research use only, not for human use.
  • Brief Description
    TAP-311 is a novel potent and selective CETP inhibitor with plasma IC50 of 62 nM.
  • Description
    TAP-311 is a novel potent and selective CETP inhibitor with plasma IC50 of 62 nM; displays >170-fold selectivity over CYPs, and has excellent pharmacokinetics in rats and robust efficacy in hamsters; shows substantially reduced lipophilicity with only modest distribution into adipose tissue, and retains potency in hypertriglyceridemic plasma in vitro and in vivo; does not increase blood pressure or plasma aldosterone levels in vivo, in contrast to torcetrapib.Dyslipidemia Phase 1 Clinical.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    TAP311
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    CETP
  • Recptor
    CETP
  • Research Area
    Cardiovascular Disease
  • Indication
    Dyslipidemia

Chemical Information

  • CAS Number
    1149362-88-8
  • Formula Weight
    710.72
  • Molecular Formula
    C34H40F6N6O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CN1N=CC(C(C=N2)=CN=C2N(C3CC(CC)N(C(OC4CCC(C(O)=O)CC4)=O)C(CC)C3)CC5=CC(C(F)(F)F)=CC(C(F)(F)F)=C5)=C1
  • Chemical Name
    4-((4-((3,5-bis(trifluoromethyl)benzyl)(5-(1-methyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)-2,6-diethylpiperidine-1-carbonyl)oxy)cyclohexane-1-carboxylic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Yamada K, et al. J Med Chem. 2017 Oct 26;60(20):8466-8481.
molnova catalog
related products
  • Ro 5-3335

    Ro 5-3335 is core binding factor (CBF) inhibitor; preferentially kills human leukemia cell lines with CBF fusion proteins (IC50 = 1.1 μM).

  • TAP-311

    TAP-311 is a novel potent and selective CETP inhibitor with plasma IC50 of 62 nM.

  • Granotapide

    Granotapide is a microsomal triglyceride transfer protein (MTP) inhibitor that treats and rather prevents atherosclerosis, coronary artery disease, metabolic syndrome, obesity, diabetes mellitus, prediabetes mellitus, and hypertension.